Contemporary short-term peri-operative outcomes of open primary retroperitoneal lymph node dissection

被引:1
|
作者
McFadden, Jacob D. [1 ]
Masterson, Timothy A. [1 ]
Cary, Clint [1 ]
机构
[1] Indiana Univ Sch Med, Dept Urol, Indianapolis, IN 46202 USA
关键词
testicular cancer; RPLND; outcomes; morbidity; complications; GERM-CELL TUMORS; TESTICULAR CANCER; PRIMARY CHEMOTHERAPY; TESTIS CANCER; COMPLICATIONS; EXPERIENCE; LYMPHADENECTOMY; MORBIDITY; IMPACT;
D O I
10.1111/bju.16506
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo provide current peri-operative outcomes and short-term complication rates for open primary retroperitoneal lymph node dissection (RPLND), with analysis of risk factors for complications.Patients and MethodsUsing the Indiana University Testicular Cancer database, we performed a retrospective analysis of all patients who underwent open primary RPLND over the study period (2018-2021). The primary outcomes of interest were the preoperative profile of patients undergoing surgery, complication rates, and identification of risk factors associated with complications. We used chi-squared, Fisher's exact and unpaired t-tests in our analyses.ResultsA total of 165 patients were identified. The median body mass index (BMI) was 28.6 kg/m2. Patients most often had clinical stage IIA (39%) or IIB testicular cancer (36%). The median estimated blood loss was 150 mL, with no transfusions required. Higher BMI was noted in patients that sustained any complication vs those with normal recovery (34.95 vs 28 kg/m2; P = 0.0042). The median length of hospital stay was 3 days. The overall complication rate was low (8.48%), with two major postoperative complications, including one case of chylous ascites (0.6%), and no deaths in the 30-day period. The study was limited by its retrospective design and short-term follow-up.ConclusionsWe found that open primary RPLND has an acceptable morbidity profile, even among a predominantly overweight cohort. Low blood loss, short hospital stay, minimal chylous ascites risk, and rare major postoperative complications should be the benchmark for retroperitoneal lymph node dissection.
引用
收藏
页码:953 / 959
页数:7
相关论文
共 50 条
  • [41] SHORT-TERM OUTCOMES OF PERI-OPERATIVE BLOOD TRANSFUSIONS IN COLORECTAL CANCER SURGERY: A PROPENSITY-ADJUSTED ANALYSIS.
    Chau, J. K.
    Bhatnagar, S.
    Abou Khalil, M.
    Morin, N.
    Vasilevsky, C.
    Ghitulescu, G.
    Faria, J.
    Boutros, M.
    DISEASES OF THE COLON & RECTUM, 2018, 61 (05) : E309 - E309
  • [42] LONG TERM CLINICAL OUTCOMES FOR PATIENTS WITH NEGATIVE PATHOLOGY (PN0) AT PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION
    Baky, Fady J.
    Liso, Nicole
    Williams, Brandon
    Tallman, Jacob
    McHugh, Deaglan
    Carver, Brett
    Funt, Samuel
    Feldman, Darren
    Sheinfeld, Joel
    Matulewicz, Richard
    JOURNAL OF UROLOGY, 2024, 211 (05): : E11 - E11
  • [43] Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy
    Douglawi, Antoin
    Calaway, Adam
    Tachibana, Isamu
    Barboza, Marcelo Panizzutti
    Speir, Ryan
    Masterson, Timothy
    Adra, Nabil
    Foster, Richard
    Einhorn, Lawrence
    Cary, Clint
    JOURNAL OF UROLOGY, 2020, 204 (01): : 96 - 101
  • [44] LONG-TERM ONCOLOGIC OUTCOMES AFTER PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION: MINIMIZING THE NEED FOR ADJUVANT CHEMOTHERAPY
    Douglawi, Antoin
    Calaway, Adam
    Tachibana, Isamu
    Barboza, Marcelo
    Masterson, Timothy
    Foster, Richard
    Cary, Clint
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1017 - E1017
  • [45] Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum
    Matulewicz, Richard S.
    Benfante, Nicole
    Funt, Samuel A.
    Feldman, Darren R.
    Carver, Brett
    Doudt, Alexander
    Knezevic, Andrea
    Sheinfeld, Joel
    JOURNAL OF UROLOGY, 2024, 211 (01): : 80 - 89
  • [46] Outcomes of Retroperitoneal Lymph Node Dissection for the Most Challenging Cases
    Silberstein, Jonathan L.
    JOURNAL OF UROLOGY, 2014, 192 (05): : 1320 - 1321
  • [47] Complications of open primary and post-chemotherapy retroperitoneal lymph node dissection for testicular cancer
    Subramanian, Vairavan S.
    Nguyen, Carvell T.
    Stephenson, Andrew J.
    Klein, Eric A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2010, 28 (05) : 504 - 509
  • [48] Retroperitoneal lymph node dissection outcomes in New South Wales
    Okullo, A.
    Dargan, J.
    Patel, M.
    BJU INTERNATIONAL, 2018, 121 : 54 - 54
  • [49] Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
    Hu, Brian
    Daneshmand, Siamak
    ADVANCES IN UROLOGY, 2018, 2018
  • [50] Ablation approach for primary liver tumors: Peri-operative outcomes
    Berger, Nicholas G.
    Herren, Josi L.
    Liu, Chrissy
    Burrow, Robert H.
    Silva, Jack P.
    Tsai, Susan
    Christians, Kathleen K.
    Gamblin, T. Clark
    JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (07) : 1493 - 1499